Profile data is unavailable for this security.
About the company
TrivarX Limited, formerly Medibio Limited, is an Australia-based mental health technology company engaged in the use of objective measures to aid in the early detection and screening of mental health conditions. Through the Company’s corporate health product, it offers mental well-being solutions for businesses and is also developing products to serve the healthcare provider market. The principal activity of the Company is development of artificial intelligence (AI)-driven, scientifically based devices for screening and diagnosis of behavioral health conditions. Its clinical research has enabled the development of proprietary algorithms for spectral analyses of sleep architecture and heart-rate variability. The Company’s lead product, MEB-001 analyses the data from a standard sleep study to identify depression at a sensitivity of over 85%. Its technology analyses the electrical signals from the brain and the heart to identify mental illness.
- Revenue in AUD (TTM)1.13m
- Net income in AUD-943.23k
- Incorporated1987
- Employees4.00
- LocationTrivarX LtdLevel 4, 100 Albert RoadSOUTH MELBOURNE 3205AustraliaAUS
- Phone+61 86189-1155
- Fax+61 39077-9233
- Websitehttps://medibio.com.au/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zelira Therapeutics Ltd | 660.00 | -3.63m | 5.95m | 8.00 | -- | -- | -- | 9,013.00 | -0.3172 | -0.3172 | 0.00006 | -0.3749 | 0.0002 | 0.0102 | 0.003 | -- | -118.74 | -50.35 | -- | -56.97 | -1,236.36 | 43.05 | -583,283.30 | -2,379.12 | 0.0244 | -6.50 | -- | -- | -99.30 | -77.07 | 90.08 | -- | -- | -- |
| Nutritional Growth Solutions Ltd | 2.95m | -3.93m | 6.66m | -- | -- | -- | -- | 2.26 | -0.0426 | -0.0426 | 0.0317 | -0.0115 | 3.26 | 4.05 | 33.35 | -- | -433.20 | -130.49 | -- | -187.56 | 26.70 | 40.32 | -132.89 | -143.99 | 0.1206 | -19.99 | -- | -- | -16.86 | 15.95 | -0.2074 | -- | -- | -- |
| Immuron Ltd | 7.29m | -5.22m | 9.15m | 7.00 | -- | 0.8119 | -- | 1.26 | -0.0226 | -0.0226 | 0.0316 | 0.0345 | 0.5675 | 1.50 | 4.40 | 1,041,000.00 | -40.62 | -27.84 | -49.64 | -30.60 | 65.39 | 70.18 | -71.58 | -182.34 | 4.19 | -- | 0.00 | -- | 48.63 | 23.67 | 24.81 | -- | -- | -- |
| Tissue Repair Ltd | 3.02m | -4.24m | 9.67m | -- | -- | 0.6954 | -- | 3.21 | -0.0701 | -0.0701 | 0.0499 | 0.2301 | 0.1777 | -- | 60.84 | -- | -24.96 | -24.25 | -26.50 | -25.27 | -- | -- | -140.49 | -518.54 | 22.40 | -- | 0.00 | -- | 236.85 | -- | -2.43 | -- | -- | -- |
| Epsilon Healthcare Ltd | 6.13m | -6.12m | 10.51m | -- | -- | -- | -- | 1.71 | -0.0164 | -0.0164 | 0.0167 | -0.0097 | 0.462 | -- | 4.95 | -- | -46.14 | -33.37 | -156.14 | -46.46 | 52.23 | 49.34 | -99.85 | -136.16 | 0.3775 | -3.92 | 1.67 | -- | -15.81 | 3.16 | -403.56 | -- | -32.83 | -- |
| Calmer Co International Ltd | 8.03m | -3.99m | 10.70m | -- | -- | 5.54 | -- | 1.33 | -0.0015 | -0.0015 | 0.0029 | 0.0006 | 1.60 | 3.29 | 14.33 | -- | -79.73 | -109.82 | -171.17 | -197.50 | 42.49 | 41.18 | -49.69 | -128.71 | 1.22 | -11.32 | 0.5482 | -- | 88.48 | 59.99 | -7.13 | -- | 27.67 | -- |
| Firebrick Pharma Ltd | 159.94k | -2.45m | 13.89m | -- | -- | 7.14 | -- | 86.82 | -0.0106 | -0.0106 | 0.0007 | 0.0077 | 0.0777 | 0.4045 | 1.30 | -- | -119.12 | -98.41 | -142.70 | -109.28 | -9.34 | -- | -1,532.61 | -5,384.55 | 4.60 | -- | 0.00 | -- | 1,920.80 | -- | -124.04 | -- | -- | -- |
| Oncosil Medical Ltd | 1.59m | -12.92m | 15.47m | 2.00 | -- | 3.23 | -- | 9.70 | -0.9425 | -0.9425 | 0.104 | 0.2028 | 0.1711 | -- | 3.47 | -- | -138.67 | -97.54 | -207.63 | -117.83 | -66.32 | -54.05 | -810.45 | -1,258.41 | -- | -386.47 | 0.011 | -- | 116.34 | -15.15 | -26.74 | -- | -6.31 | -- |
| Vitura Health Ltd | 124.04m | 3.28m | 27.84m | 119.00 | 7.78 | 0.577 | 5.25 | 0.2244 | 0.0054 | 0.0054 | 0.2034 | 0.0728 | 1.69 | 16.43 | 10.46 | -- | 4.11 | 12.75 | 5.72 | 17.62 | 27.21 | 30.97 | 2.43 | 6.06 | 1.05 | 9.50 | 0.2009 | -- | 0.1341 | 298.23 | -5.35 | -- | 129.38 | -- |
| TrivarX Ltd | 1.13m | -943.23k | 28.84m | 4.00 | -- | 1.22 | -- | 25.46 | -0.0018 | -0.0018 | 0.0023 | 0.0204 | 0.0923 | -- | -- | -- | -7.68 | -33.47 | -8.32 | -37.46 | -- | -- | -83.27 | -373.85 | -- | -27.05 | 0.0132 | -- | 26.38 | 3.89 | 34.25 | -- | 6.29 | -- |
| Little Green Pharma Ltd | 38.49m | 5.86m | 33.64m | -- | 5.68 | 0.3909 | 3.47 | 0.874 | 0.0194 | 0.0194 | 0.1268 | 0.2814 | 0.4262 | 0.8199 | 14.01 | -- | 6.48 | -- | 7.09 | -- | 67.46 | -- | 15.21 | -- | 0.8728 | -4.71 | 0.0541 | -- | 43.67 | -- | 140.77 | -- | -- | -- |
| Avecho Biotechnology Ltd | 1.38m | -3.62m | 36.73m | 29.00 | -- | 38.46 | -- | 26.61 | -0.0011 | -0.0011 | 0.0004 | 0.0003 | 0.2115 | 4.46 | 1.91 | -- | -55.49 | -61.23 | -72.92 | -73.27 | 62.27 | 55.45 | -262.41 | -382.04 | 4.53 | -8.03 | 0.0647 | -- | 139.19 | -23.20 | 9.15 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| FIL Investment Management (Hong Kong) Ltd.as of 31 Dec 2025 | 33.29m | 2.89% |
| FIL Pensions Managementas of 30 Jun 2025 | 9.21m | 0.80% |
